Anatara Lifesciences (ANR)
Anatara Lifesciences Ltd. engages in the development of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. It also develops and commercializes Detach, a non-antibiotic therapy that prevents and treats diarrhea in piglets. The company was founded by Tracey Mynott on July 15, 2010 and is headquartered in Brisbane, Australia.
|Market Price at 13-12-2017||$1.70|
|Price to Earnings Ratio||-33.39|
|Market Capitalisation||$83.51 (million)|
|Return on Equity (ROE)||-12.31%|